18 results on '"Adam Walker"'
Search Results
2. An effective ‘push–pull’ control strategy for European tarnished plant bug, Lygus rugulipennis (Heteroptera: Miridae), in strawberry using synthetic semiochemicals
- Author
-
Chantelle Jay, Bethan Shaw, Michelle T. Fountain, Greg Deakin, Adam Walker, Dudley I. Farman, and David Hall
- Subjects
Male ,Nymph ,0106 biological sciences ,Integrated pest management ,S1 ,Fragaria ,01 natural sciences ,Pheromones ,Heteroptera ,Crop ,Toxicology ,Animals ,Lygus rugulipennis ,QD ,Sex Attractants ,Semiochemical ,biology ,fungi ,food and beverages ,General Medicine ,biology.organism_classification ,Miridae ,010602 entomology ,Insect Science ,Female ,PEST analysis ,Tarnished plant bug ,Agronomy and Crop Science ,010606 plant biology & botany - Abstract
Background European tarnished plant bug, Lygus rugulipennis (Heteroptera: Miridae), is a polyphagous pest damaging a range of arable and horticultural crops. Management is reliant upon chemical insecticides for control. These studies developed a synthetic semiochemical push-pull control strategy to reduce numbers of L. rugulipennis and subsequent fruit damage in UK strawberry crops. Using a series of small-field experiments and testing in commercial strawberry crops we explored the efficacy of hexyl butyrate (HB), as the push element and female sex pheromone combined with phenylacetaldehyde as the pull. Results HB dispensers placed 1.0, 3.5, 5.0, and 7.0 m from all-green Unitraps baited with the L. rugulipennis female sex pheromone significantly reduced male catches by 99%, 54% 44% and 20%, compared to untreated control, respectively. Subsequently, HB dispensers at 2 m intervals along the crop row (the push), combined with a perimeter pull, in commercial crops, reduced numbers of adult and nymph L. rugulipennis by up to 80% in organic strawberry crops compared to the untreated control. Finally, the push-pull system halved fruit damage (8%) compared to the untreated areas (16%) in conventional crops. In organic strawberry crops, 90% of untreated strawberries had some mirid damage compared to only 41-51% in the push-pull treated areas. Conclusion To our knowledge, this is the first demonstration of a push-pull approach using synthetic semiochemicals giving a significant reduction in crop damage by mirids and paves the way for non-pesticide control of a range of mirid species on multiple crops. This article is protected by copyright. All rights reserved.
- Published
- 2021
3. Engineered expression of the invertebrate-specific scorpion toxin AaHIT reduces adult longevity and female fecundity in the diamondback moth Plutella xylostella
- Author
-
Victoria C Norman, Joss Teal, Luxziyah Akilan, Ruth Carter, Hamid Anees Siddiqui, Erica Lovett, Christine M Reitmayer, Philip T. Leftwich, Xuejiao Xu, Tim Harvey-Samuel, Luke Alphey, Tarig Dafa'alla, and Adam Walker
- Subjects
Male ,0106 biological sciences ,media_common.quotation_subject ,Transgene ,Longevity ,Scorpion Venoms ,Context (language use) ,Moths ,Biology ,01 natural sciences ,Lepidoptera genitalia ,Animals ,Transgenes ,media_common ,Genetics ,Diamondback moth ,Effector ,fungi ,General Medicine ,Fecundity ,biology.organism_classification ,Phenotype ,010602 entomology ,Fertility ,Larva ,Insect Science ,Female ,PEST analysis ,Agronomy and Crop Science ,010606 plant biology & botany - Abstract
BACKGROUNDPrevious Genetic Pest Management (GPM) systems in diamondback moth (DBM) have relied on expressing lethal proteins (‘effectors’) that are ‘cell-autonomous’ i.e. do not leave the cell they are expressed in. To increase the flexibility of future GPM systems in DBM, we aimed to assess the use of a non cell-autonomous, invertebrate-specific, neurotoxic effector – the scorpion toxin AaHIT. This AaHIT effector was designed to be secreted by expressing cells, potentially leading to effects on distant cells, specifically neuromuscular junctions.RESULTSExpression of AaHIT caused a ‘shaking/quivering’ phenotype which could be repressed by provision of an antidote (tetracycline); a phenotype consistent with the AaHIT mode-of-action. This effect was more pronounced when AaHIT expression was driven by the Hr5/ie1 promoter (82.44% of males, 65.14% of females) rather than Op/ie2 (57.35% of males, 48.39% of females). Contrary to expectations, the shaking phenotype and observed fitness costs were limited to adults where they caused severe reductions in mean longevity (–81%) and median female fecundity (–93%). qPCR of AaHIT expression patterns and analysis of piggyBac-mediated transgene insertion sites suggest that restriction of observed effects to the adult stages may be due to influence of local genomic environment on the tetO-AaHIT transgene.CONCLUSIONWe have demonstrated the feasibility of using non cell-autonomous effectors within a GPM context for the first time in the Lepidoptera, one of the most economically damaging orders of insects. These findings provide a framework for extending this system to other pest Lepidoptera and to other secreted effectors.
- Published
- 2020
4. Quantifying disease activity in rheumatoid arthritis with the TSPO PET ligand 18F-GE-180 and comparison with 18F-FDG and DCE-MRI
- Author
-
Mats Bergström, Danielle M. Gerlag, Disala Fernando, Pilar Jimenez-Royo, Martin J. Graves, Marius de Groot, A. Ostor, Tim D. Fryer, Adam Walker, Robert L. Janiczek, Alexandra R. Roberts, Neel Patel, Roido Manavaki, Nicolas Wisniacki, Prafull Mistry, Yakshitha Karkera, Jimenez-Royo, Pilar [0000-0003-1959-6791], and Apollo - University of Cambridge Repository
- Subjects
lcsh:Medical physics. Medical radiology. Nuclear medicine ,biology ,business.industry ,Fdg ,lcsh:R895-920 ,Wrist ,medicine.disease ,Positive correlation ,Disease activity ,medicine.anatomical_structure ,PET ,In vivo ,Rheumatoid arthritis ,Pet ligand ,medicine ,Translocator protein ,biology.protein ,Radiology, Nuclear Medicine and imaging ,business ,Nuclear medicine ,Cardiac imaging ,Tspo ,Original Research ,MRI - Abstract
Purpose While the aetiology of rheumatoid arthritis (RA) remains unclear, many of the inflammatory components are well characterised. For diagnosis and therapy evaluation, in vivo insight into these processes would be valuable. Various imaging probes have shown value including dynamic contrast-enhanced (DCE) MRI and PET/CT using 18F-fluorodeoxyglucose (18F-FDG) or tracers targeting the translocator protein (TSPO). To evaluate 18F-GE-180, a novel TSPO PET tracer, for detecting and quantifying disease activity in RA, we compared 18F-GE-180 uptake with that of 18F-FDG and DCE-MRI measures of inflammation. Methods Eight RA patients with moderate-to-high, stable disease activity and active disease in at least one wrist were included in this study (NCT02350426). Participants underwent PET/CT examinations with 18F-GE-180 and 18F-FDG on separate visits, covering the shoulders and from the pelvis to the feet, including hands and wrists. DCE-MRI was performed on one affected hand. Uptake was compared visually between tracers as judged by an experienced radiologist and quantitatively using the maximum standardised uptake value (SUVmax). Uptake for both tracers was correlated with DCE-MRI parameters of inflammation, including the volume transfer coefficient Ktrans using Pearson correlation (r). Results PET/CT imaging with 18F-GE-180 in RA patients showed marked extra-synovial uptake around the affected joints. Overall sensitivity for detecting clinically affected joints was low (14%). 18F-GE-180 uptake did not or only weakly correlate with DCE-MRI parameters in the wrist (r = 0.09–0.31). 18F-FDG showed higher sensitivity for detecting symptomatic joints (34%), as well as strong positive correlation with DCE-MRI parameters (SUVmax vs. Ktrans: r = 0.92 for wrist; r = 0.68 for metacarpophalangeal joints). Conclusions The correlations between DCE-MRI parameters and 18F-FDG uptake support use of this PET tracer for quantification of inflammatory burden in RA. The TSPO tracer 18F-GE-180, however, has shown limited use for the investigation of RA due to its poor sensitivity and ability to quantify disease activity in RA.
- Published
- 2019
5. Novel Bispecific Domain Antibody to LRP6 Inhibits Wnt and R-spondin Ligand-Induced Wnt Signaling and Tumor Growth
- Author
-
Christopher A. Shelton, Muhammad Al-Hajj, Louisa Anderson, Jeremy Griggs, Sarah Friel, Michael Steward, Gavin Jones, William E. Fieles, Heather Jackson, Adam Walker, David W Granger, Trevor Anthony Kenneth Wattam, Daniel Rycroft, and James Tunstead
- Subjects
Male ,0301 basic medicine ,Cancer Research ,medicine.drug_class ,Fibrosarcoma ,Biology ,Ligands ,Monoclonal antibody ,Mice ,03 medical and health sciences ,Mice, Inbred NOD ,Cell Line, Tumor ,Antibodies, Bispecific ,medicine ,Animals ,Humans ,Receptor ,Wnt Signaling Pathway ,Molecular Biology ,Mice, Inbred BALB C ,HEK 293 cells ,Wnt signaling pathway ,LRP6 ,LRP5 ,Ligand (biochemistry) ,Xenograft Model Antitumor Assays ,Mice, Inbred C57BL ,Wnt Proteins ,HEK293 Cells ,030104 developmental biology ,Oncology ,Cell culture ,Low Density Lipoprotein Receptor-Related Protein-6 ,Cancer research ,Female ,Thrombospondins - Abstract
Aberrant WNT signaling is associated with the formation and growth of numerous human cancer types. The low-density lipoprotein receptor-related protein 6 (LRP6) is the least redundant component of the WNT receptor complex with two independent WNT ligand-binding sites. Using domain antibody (dAb) technology, a bispecific antibody (GSK3178022) to LRP6 was identified that is capable of blocking stimulation in the presence of a range of WNT and R-spondin (RSPO) ligands in vitro. GSK3178022 was also efficacious in reducing WNT target gene expression in vivo, in both cancer cell line and patient-derived xenograft models, and delays tumor growth in a patient-derived RSPO fusion model of colorectal cancer. Implications: This article demonstrates the inhibition of a key oncogenic receptor, intractable to mAb inhibition due to multiple independent ligand interaction sites, using an innovative dAb approach. Mol Cancer Res; 14(9); 859–68. ©2016 AACR.
- Published
- 2016
6. Environmental cues and extended estuarine residence in seaward migrating eels (Anguilla australis)
- Author
-
Danny Lovett, Chris A. Belcher, Jed I. Macdonald, Simon J. Nicol, John R. Morrongiello, David A. Crook, and Adam Walker
- Subjects
endocrine system ,geography ,animal structures ,geography.geographical_feature_category ,Brackish water ,biology ,Estuary ,Aquatic Science ,biology.organism_classification ,Late summer ,Fishery ,Anguilla australis ,Fresh water ,Water temperature ,Anguillidae ,Environmental science - Abstract
Spawning migration by freshwater eels to their marine spawning grounds is widely considered to be direct and rapid; however, emerging evidence suggests that eel migratory behaviour is more complex than previously thought, with potential implications for eel conservation and management. Over a 5-year period, we tagged 97 yellow-phase short-finned eels Anguilla australis with acoustic transmitters in the freshwater reaches of a south-eastern Australian river to: (i) examine environmental correlates associated with seaward migration; (ii) test the hypothesis that migration is rapid and direct once initiated and (iii) assess individual variation in behaviour associated with seaward migration. Twenty-three of the tagged eels migrated from fresh water into the estuary, whilst the remainder stayed within fresh water. Movement was detected primarily at night and eels entered the estuary throughout the year, with an increase in frequency over summer and following high river flows. Time in the estuary ranged from 1 to 305 days (median: 77 days). Movement into the sea was influenced primarily by the lunar phase, and to a lesser degree by water temperature, and occurred from late summer to early autumn. The extended residence and complex movements of migrating eels in the estuary suggest that they are considerably more vulnerable to exploitation than would be predicted by the generalised eel migration model of direct movement out to sea.
- Published
- 2014
7. Engineered Female-Specific Lethality for Control of Pest Lepidoptera
- Author
-
Guoliang Fu, Sinead O'Connell, Tarig Dafa'alla, Luke Alphey, Nerys Humphrey-Jones, Neil I. Morrison, Deborah Granville, Tim Harvey-Samuel, Thea Marubbi, Andrea Miles, Adam Walker, and Li Jin
- Subjects
Male ,animal structures ,Doublesex ,Biomedical Engineering ,Zoology ,Moths ,Biochemistry, Genetics and Molecular Biology (miscellaneous) ,Animals, Genetically Modified ,Lepidoptera genitalia ,Sterile insect technique ,Animals ,Pest Control, Biological ,Diamondback moth ,biology ,business.industry ,Sterilization, Reproductive ,fungi ,Pest control ,Plutella ,General Medicine ,biology.organism_classification ,Biotechnology ,Lepidoptera ,Insect Proteins ,Female ,Genes, Lethal ,PEST analysis ,business ,Pink bollworm - Abstract
The sterile insect technique (SIT) is a pest control strategy involving the mass release of radiation-sterilized insects, which reduce the target population through nonviable matings. In Lepidoptera, SIT could be more broadly applicable if the deleterious effects of sterilization by irradiation could be avoided. Moreover, male-only release can improve the efficacy of SIT. Adequate methods of male-only production in Lepidoptera are currently lacking, in contrast to some Diptera. We describe a synthetic genetic system that allows male-only moth production for SIT and also replaces radiation sterilization with inherited female-specific lethality. We sequenced and characterized the doublesex (dsx) gene from the pink bollworm (Pectinophora gossypiella). Sex-alternate splicing from dsx was used to develop a conditional lethal genetic sexing system in two pest moths: the diamondback moth (Plutella xylostella) and pink bollworm. This system shows promise for enhancing existing pink bollworm SIT, as well as broadening SIT-type control to diamondback moth and other Lepidoptera.
- Published
- 2013
8. The INNs and outs of antibody nonproprietary names
- Author
-
Paul W. H. I. Parren, Markus Enzelberger, John M. Lambert, Paul Carter, Mary Reilly, Tim Jones, John McCafferty, David C. Lowe, Mike Clark, Julian Davies, Dimiter S. Dimitrov, Max Vásquez, Isidro Hötzel, Robert G.E. Holgate, Jane A. Gross, Bassil I. Dahiyat, Kerry A. Chester, Matthew P. Baker, Martin Steegmaier, John S. Haurum, Martin J. Glennie, Victoria C. Smith, Dennis R. Burton, Richard A.J. Janssen, Stefan Dübel, Andrew George Popplewell, Hendrik J. Rademaker, Andrew Bradbury, Andreas Plückthun, Herren Wu, Thomas Schirrmann, S. L. Martin, Adam Walker, and James S. Huston
- Subjects
0301 basic medicine ,medicine.drug_class ,International Immunogenetics Information System (IMGT) ,Immunology ,monoclonal ,Scientific literature ,Computational biology ,Monoclonal antibody ,World Health Organization (WHO) ,Antibodies ,World health ,Scientific evidence ,03 medical and health sciences ,framework ,Terminology as Topic ,antibody ,medicine ,Animals ,Humans ,Immunology and Allergy ,definition ,Complementarity Determining Region (CDR) ,International Nonproprietary Name (INN) ,biology ,humanized ,business.industry ,Expert group ,030104 developmental biology ,Drug development ,chimeric ,Perspective ,Identity (object-oriented programming) ,biology.protein ,Antibody ,business - Abstract
An important step in drug development is the assignment of an International Nonproprietary Name (INN) by the World Health Organization (WHO) that provides healthcare professionals with a unique and universally available designated name to identify each pharmaceutical substance. Monoclonal antibody INNs comprise a –mab suffix preceded by a substem indicating the antibody type, e.g., chimeric (-xi-), humanized (-zu-), or human (-u-). The WHO publishes INN definitions that specify how new monoclonal antibody therapeutics are categorized and adapts the definitions to new technologies. However, rapid progress in antibody technologies has blurred the boundaries between existing antibody categories and created a burgeoning array of new antibody formats. Thus, revising the INN system for antibodies is akin to aiming for a rapidly moving target. The WHO recently revised INN definitions for antibodies now to be based on amino acid sequence identity. These new definitions, however, are critically flawed as they are ambiguous and go against decades of scientific literature. A key concern is the imposition of an arbitrary threshold for identity against human germline antibody variable region sequences. This leads to inconsistent classification of somatically mutated human antibodies, humanized antibodies as well as antibodies derived from semi-synthetic/synthetic libraries and transgenic animals. Such sequence-based classification implies clear functional distinction between categories (e.g., immunogenicity). However, there is no scientific evidence to support this. Dialog between the WHO INN Expert Group and key stakeholders is needed to develop a new INN system for antibodies and to avoid confusion and miscommunication between researchers and clinicians prescribing antibodies.
- Published
- 2016
9. A functional genomics approach reveals novel quantitative trait loci associated with platelet signaling pathways
- Author
-
Willem H. Ouwehand, Nilesh J. Samani, Panos Deloukas, Frank Dudbridge, Jan-Willem N. Akkerman, Sarah L. Bray, Alison J. Coffey, Michael Steward, Marc Hoylaerts, Jonathan Stephens, Catherine M. Rice, Angela Rankin, Alison H. Goodall, Nicholas A. Watkins, Stephen F. Garner, Adam Walker, Philippa Burns, David Bentley, Jane Rogers, Richard W. Farndale, Chris I. Jones, Mark E. Earthrowl, W. Angenent, Kerstin Koch, and Bernard de Bono
- Subjects
Blood Platelets ,Male ,Candidate gene ,Genotype ,Quantitative Trait Loci ,Immunology ,Receptors, Cell Surface ,Single-nucleotide polymorphism ,Quantitative trait locus ,Biology ,Polymorphism, Single Nucleotide ,Biochemistry ,Cell Degranulation ,White People ,Platelet degranulation ,Humans ,Inositol 1,4,5-Trisphosphate Receptors ,SNP ,Platelet activation ,Allele ,3' Untranslated Regions ,Alleles ,Genetics ,Genomics ,Cell Biology ,Hematology ,Platelet Activation ,Molecular biology ,Adenosine Diphosphate ,Europe ,Minor allele frequency ,P-Selectin ,Gene Expression Regulation ,Female ,Collagen ,Signal Transduction - Abstract
Platelet response to activation varies widely between individuals but shows interindividual consistency and strong heritability. The genetic basis of this variation has not been properly explored. We therefore systematically measured the effect on function of sequence variation in 97 candidate genes in the collagen and adenosine-diphosphate (ADP) signaling pathways. Resequencing of the genes in 48 European DNA samples nearly doubled the number of known single nucleotide polymorphisms (SNPs) and informed the selection of 1327 SNPs for genotyping in 500 healthy Northern European subjects with known platelet responses to collagen-related peptide (CRP-XL) and ADP. This identified 17 novel associations with platelet function (P < .005) accounting for approximately 46% of the variation in response. Further investigations with platelets of known genotype explored the mechanisms behind some of the associations. SNPs in PEAR1 associated with increased platelet response to CRP-XL and increased PEAR1 protein expression after platelet degranulation. The minor allele of a 3′ untranslated region (UTR) SNP (rs2769668) in VAV3 was associated with higher protein expression (P = .03) and increased P-selectin exposure after ADP activation (P = .004). Furthermore the minor allele of the intronic SNP rs17786144 in ITPR1 modified Ca2+ levels after activation with ADP (P < .004). These data provide novel insights into key hubs within platelet signaling networks.
- Published
- 2009
10. Pest control and resistance management through release of insects carrying a male-selecting transgene
- Author
-
Anthony M. Shelton, Thea Marubbi, Adam Walker, T.G. Emyr Davies, Nina Alphey, Luke Alphey, Neil I. Morrison, Kevin Gorman, Hilda L. Collins, Tim Harvey-Samuel, Yao Ju, and Simon Warner
- Subjects
0106 biological sciences ,Integrated pest management ,Male ,Physiology ,Pest ,Plant Science ,Moths ,01 natural sciences ,Transgenic ,Animals, Genetically Modified ,Insecticide Resistance ,Sterile insect technique ,Structural Biology ,Bacillus thuringiensis ,Plutella xylostella ,Transgenes ,2. Zero hunger ,0303 health sciences ,education.field_of_study ,Diamondback moth ,Agricultural and Biological Sciences(all) ,biology ,food and beverages ,Plants, Genetically Modified ,Female ,General Agricultural and Biological Sciences ,Genetic Engineering ,Biotechnology ,Research Article ,Crops, Agricultural ,Population ,Brassica ,General Biochemistry, Genetics and Molecular Biology ,03 medical and health sciences ,Animals ,education ,Pest Control, Biological ,Ecology, Evolution, Behavior and Systematics ,030304 developmental biology ,Biochemistry, Genetics and Molecular Biology(all) ,business.industry ,fungi ,Pest control ,Cell Biology ,biology.organism_classification ,010602 entomology ,Cry1Ac ,PEST analysis ,business ,Insecticide resistance management ,Insect ,Developmental Biology - Abstract
Background Development and evaluation of new insect pest management tools is critical for overcoming over-reliance upon, and growing resistance to, synthetic, biological and plant-expressed insecticides. For transgenic crops expressing insecticidal proteins from the bacterium Bacillus thuringiensis (‘Bt crops’) emergence of resistance is slowed by maintaining a proportion of the crop as non-Bt varieties, which produce pest insects unselected for resistance. While this strategy has been largely successful, multiple cases of Bt resistance have now been reported. One new approach to pest management is the use of genetically engineered insects to suppress populations of their own species. Models suggest that released insects carrying male-selecting (MS) transgenes would be effective agents of direct, species-specific pest management by preventing survival of female progeny, and simultaneously provide an alternative insecticide resistance management strategy by introgression of susceptibility alleles into target populations. We developed a MS strain of the diamondback moth, Plutella xylostella, a serious global pest of crucifers. MS-strain larvae are reared as normal with dietary tetracycline, but, when reared without tetracycline or on host plants, only males will survive to adulthood. We used this strain in glasshouse-cages to study the effect of MS male P. xylostella releases on target pest population size and spread of Bt resistance in these populations. Results Introductions of MS-engineered P. xylostella males into wild-type populations led to rapid pest population decline, and then elimination. In separate experiments on broccoli plants, relatively low-level releases of MS males in combination with broccoli expressing Cry1Ac (Bt broccoli) suppressed population growth and delayed the spread of Bt resistance. Higher rates of MS male releases in the absence of Bt broccoli were also able to suppress P. xylostella populations, whereas either low-level MS male releases or Bt broccoli alone did not. Conclusions These results support theoretical modeling, indicating that MS-engineered insects can provide a powerful pest population suppressing effect, and could effectively augment current Bt resistance management strategies. We conclude that, subject to field confirmation, MS insects offer an effective and versatile control option against P. xylostella and potentially other pests, and may reduce reliance on and protect insecticide-based approaches, including Bt crops.
- Published
- 2015
11. Pharmacokinetic Characteristics, Pharmacodynamic Effect and In Vivo Antiviral Efficacy of Liver-Targeted Interferon Alpha
- Author
-
Fiona M. Kelly, Robert Hamatake, Daniel Rycroft, Rob Prince, Edward Coulstock, Marie Davies, Milan Ovečka, John D. Morrey, Sarah Friel, Adam Walker, Laura Goodall, Jane K. Sosabowski, and Armin Sepp
- Subjects
Alpha interferon ,lcsh:Medicine ,Mice, Transgenic ,Pharmacology ,Biology ,Antiviral Agents ,Mice ,In vivo ,Interferon ,medicine ,Animals ,lcsh:Science ,Mice, Inbred BALB C ,Multidisciplinary ,lcsh:R ,Gene targeting ,Interferon-alpha ,Correction ,Hepatitis B ,medicine.disease ,Fusion protein ,In vitro ,Liver ,biology.protein ,lcsh:Q ,Antibody ,Research Article ,medicine.drug - Abstract
Interferon alpha (IFNα) is used for the treatment of hepatitis B virus infection, and whilst efficacious, it is associated with multiple adverse events caused by systemic exposure to interferon. We therefore hypothesise that targeting IFN directly to the intended site of action in the liver would reduce exposure in blood and peripheral tissue and hence improve the safety and tolerability of IFNα therapy. Furthermore we investigated whether directing IFN to the reservoir of infection in the liver may improve antiviral efficacy by increasing local concentration in target organs and tissues. Our previous results show that the mIFNα2 fused to an ASGPR specific liver targeting antibody, DOM26h-196-61, results in a fusion protein which retains the activity of both fusion partners when measured in vitro. In vivo targeting of the liver by mIFNα2-DOM26h-196-61, hereafter referred to as targeted mIFNα2, was observed in microSPECT imaging studies in mice. In this study we show by pharmacokinetic analysis that antibody mediated liver-targeting results in increased uptake and exposure of targeted mIFNα2 in target tissues, and correspondingly reduced uptake and exposure in systemic circulation, clearance organs and non-target tissues. We also show that cytokine activity and antiviral activity of liver-targeted IFN is observed in vivo, but that, contrary to expectations, liver-targeting of mIFNα2 using ASGPR specific dAbs actually leads to a reduced pharmacodynamic effect in target organs and lower antiviral activity in vivo when compared to non-targeted mIFNα2-dAb fusions.
- Published
- 2014
12. Liver-targeting of interferon-alpha with tissue-specific domain antibodies
- Author
-
Edward Coulstock, Adam Walker, Julie Foster, Jerome Burnet, Grainne Dunlevy, Jane K. Sosabowski, Armin Sepp, Rob Prince, Milan Ovečka, Laura Goodall, Marie Davies, and Clare Mudd
- Subjects
Drugs and Devices ,Drug Research and Development ,Mouse ,Radionuclide imaging ,Molecular Sequence Data ,Cancer Treatment ,PET imaging ,Alpha interferon ,lcsh:Medicine ,Biology ,Mice ,Model Organisms ,Antigen ,Antibody Therapy ,In vivo ,Interferon ,Drug Discovery ,medicine ,Animals ,Humans ,Pharmacokinetics ,Amino Acid Sequence ,lcsh:Science ,Autoantibodies ,Drug Distribution ,SPECT imaging ,Multidisciplinary ,Cell fusion ,Sequence Homology, Amino Acid ,lcsh:R ,Interferon-alpha ,Animal Models ,Fusion protein ,Pharmacodynamics ,Oncology ,Liver ,Immunology ,Nuclear medicine ,biology.protein ,Medicine ,Asialoglycoprotein receptor ,lcsh:Q ,Antibody ,Radiology ,medicine.drug ,Research Article ,Biotechnology - Abstract
Interferon alpha (IFNα) is used for the treatment of hepatitis C infection and whilst efficacious it is associated with multiple adverse events including reduced leukocyte, erythrocyte, and platelet counts, fatigue, and depression. These events are most likely caused by systemic exposure to interferon. We therefore hypothesise that targeting the therapeutic directly to the intended site of action in the liver would reduce exposure in blood and peripheral tissue and hence improve the safety and tolerability of IFNα therapy. We genetically fused IFN to a domain antibody (dAb) specific to a hepatocyte restricted antigen, asialoglycoprotein receptor (ASGPR). Our results show that the murine IFNα2 homolog (mIFNα2) fused to an ASGPR specific dAb, termed DOM26h-196-61, could be expressed in mammalian tissue culture systems and retains the desirable biophysical properties and activity of both fusion partners when measured in vitro. Furthermore a clear increase in in vivo targeting of the liver by mIFNα2-ASGPR dAb fusion protein, compared to that observed with either unfused mIFNα2 or mIFNα2 fused to an isotype control dAb VHD2 (which does not bind ASGPR) was demonstrated using microSPECT imaging. We suggest that these findings may be applicable in the development of a liver-targeted human IFN molecule with improved safety and patient compliance in comparison to the current standard of care, which could ultimately be used as a treatment for human hepatitis virus infections.
- Published
- 2013
13. Field performance of a genetically engineered strain of pink bollworm
- Author
-
Gregory S. Simmons, Robert Rose, Adam Walker, John Claus, Andrew R. McKemey, Ernie D. Miller, Luke Alphey, Bruce E. Tabashnik, Robert T. Staten, Neil I. Morrison, Christl A. Donnelly, Caroline E. Phillips, Guolei Tang, Guoliang Fu, Sinead O'Connell, Mickey Sledge, and Medical Research Council (MRC)
- Subjects
Environmental Impacts ,Male ,FITNESS ,Agricultural Biotechnology ,lcsh:Medicine ,Insect ,Moths ,Animals, Genetically Modified ,Sexual Behavior, Animal ,Sterile insect technique ,GELECHIIDAE ,lcsh:Science ,Animal Management ,media_common ,education.field_of_study ,Multidisciplinary ,biology ,Genetically Modified Organisms ,Strain (biology) ,Agriculture ,LEPIDOPTERA ,DOMINANT ,Science & Technology - Other Topics ,VECTORS ,Female ,Agrochemicals ,Genetic Engineering ,Transgenic Animals ,Research Article ,Biotechnology ,General Science & Technology ,media_common.quotation_subject ,Population ,MOSQUITOS ,SEXING STRAINS ,Agricultural Production ,Integrated Control ,SYSTEMS ,MD Multidisciplinary ,Animals ,Humans ,Pesticides ,Pest Control, Biological ,education ,Biology ,Science & Technology ,MULTIDISCIPLINARY SCIENCES ,business.industry ,fungi ,lcsh:R ,Pest control ,MEDITERRANEAN FRUIT-FLY ,Reproducibility of Results ,INSECT ,biology.organism_classification ,Luminescent Proteins ,Logistic Models ,Microscopy, Fluorescence ,Infertility ,Biological dispersal ,Plant Biotechnology ,lcsh:Q ,Pest Control ,PEST analysis ,business ,Animal Genetics ,Zoology ,Entomology ,Transgenics ,Pink bollworm - Abstract
Pest insects harm crops, livestock and human health, either directly or by acting as vectors of disease. The Sterile Insect Technique (SIT) – mass-release of sterile insects to mate with, and thereby control, their wild counterparts – has been used successfully for decades to control several pest species, including pink bollworm, a lepidopteran pest of cotton. Although it has been suggested that genetic engineering of pest insects provides potential improvements, there is uncertainty regarding its impact on their field performance. Discrimination between released and wild moths caught in monitoring traps is essential for estimating wild population levels. To address concerns about the reliability of current marking methods, we developed a genetically engineered strain of pink bollworm with a heritable fluorescent marker, to improve discrimination of sterile from wild moths. Here, we report the results of field trials showing that this engineered strain performed well under field conditions. Our data show that attributes critical to SIT in the field – ability to find a mate and to initiate copulation, as well as dispersal and persistence in the release area – were comparable between the genetically engineered strain and a standard strain. To our knowledge, these represent the first open-field experiments with a genetically engineered insect. The results described here provide encouragement for the genetic control of insect pests.
- Published
- 2011
14. Anti-serum albumin domain antibodies in the development of highly potent, efficacious and long-acting interferon
- Author
-
Fiona C. Cook, Grainne Dunlevy, Peter Topley, Adam Walker, Marie Davies, Daniel Rycroft, Tom Herbert, Steve Holmes, Lucy J. Holt, Chris Herring, and Laurent Jespers
- Subjects
Agonist ,medicine.drug_class ,Recombinant Fusion Proteins ,Serum albumin ,Bioengineering ,Pharmacology ,Interferon alpha-2 ,Protein Engineering ,Biochemistry ,Antibodies ,In vivo ,medicine ,Tumor Cells, Cultured ,Potency ,Humans ,Molecular Biology ,Serum Albumin ,Antiserum ,biology ,Chemistry ,Albumin ,Interferon-alpha ,Surface Plasmon Resonance ,Human serum albumin ,Receptor antagonist ,Recombinant Proteins ,biology.protein ,Biotechnology ,medicine.drug - Abstract
Serum albumin-binding domain antibodies (AlbudAbs) have previously been shown to greatly extend the serum half-life of the interleukin-1 receptor antagonist IL-1ra. We have subsequently extended this approach to look at the in vitro activity, in vivo efficacy and pharmacokinetics of an agonist molecule, interferon (IFN)-alpha2b, fused to an AlbudAb. Here we describe this molecule and show that in this format AlbudAb half-life extension technology displays significant advantages in comparison with other methods of half-life extension, in particular genetic fusion to serum albumin. When compared directly IFN-alpha2b fused to an Albudab shows higher potency, increased serum half-life and greater efficacy than human serum albumin fused to IFN-alpha2b. AlbudAbs are therefore an ideal platform technology for creation of therapeutics with agonist activity and long serum half-lives.
- Published
- 2010
15. The identification of beta-hydroxy carboxylic acids as selective MMP-12 inhibitors
- Author
-
Augustin J. Amour, Simon Gaines, Steve P. Watson, Stephen Lewis Martin, Danielle Egan, Máire A. Convery, Adam Walker, Robert H. Smith, John Strelow, David Brown, Ian Peter Holmes, Onkar M.P. Singh, Suzanne J. Baddeley, Olivier Lorthioir, Jeffrey W. Gross, and Shane Herbert
- Subjects
Molecular model ,Stereochemistry ,Carboxylic acid ,High-throughput screening ,Clinical Biochemistry ,Guinea Pigs ,Carboxylic Acids ,Pharmaceutical Science ,Matrix Metalloproteinase Inhibitors ,Crystallography, X-Ray ,Biochemistry ,Chemical synthesis ,Structure-Activity Relationship ,Matrix Metalloproteinase 12 ,Drug Discovery ,Hydrolase ,Animals ,Humans ,Protease Inhibitors ,Molecular Biology ,chemistry.chemical_classification ,Binding Sites ,biology ,Chemistry ,Organic Chemistry ,In vitro ,Enzyme ,Enzyme inhibitor ,Drug Design ,biology.protein ,Molecular Medicine - Abstract
A new class of selective MMP-12 inhibitors have been identified via high throughput screening. Crystallization with MMP-12 confirmed the mode of binding and allowed initial optimization to be carried out using classical structure based design.
- Published
- 2009
16. Functional genomics in zebrafish permits rapid characterization of novel platelet membrane proteins
- Author
-
Jaap-Jan Zwaginga, Chris I. Jones, Derek L. Stemple, Marie N. O'Connor, Ana Cvejic, Hans Deckmyn, Frank Dudbridge, Iain C. Macaulay, Nicholas A. Watkins, Isabelle I. Salles, Alison H. Goodall, Sarah L. Bray, Adam Walker, Bernard de Bono, Michael Steward, Willem H. Ouwehand, and Stephen F. Garner
- Subjects
Blood Platelets ,Embryo, Nonmammalian ,Morpholino ,Platelet Aggregation ,Immunology ,Blotting, Western ,030204 cardiovascular system & hematology ,Biology ,Platelet membrane glycoprotein ,Biochemistry ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Animals ,Humans ,Platelet ,Thrombus ,Zebrafish ,030304 developmental biology ,Oligonucleotide Array Sequence Analysis ,0303 health sciences ,Gene knockdown ,Gene Expression Profiling ,Lasers ,Membrane Proteins ,Thrombosis ,Cell Biology ,Hematology ,Genomics ,Oligonucleotides, Antisense ,Zebrafish Proteins ,medicine.disease ,biology.organism_classification ,Platelets and Thrombopoiesis ,Molecular biology ,Phenotype ,Membrane protein ,BAMBI - Abstract
In this study, we demonstrate the suitability of the vertebrate Danio rerio (zebrafish) for functional screening of novel platelet genes in vivo by reverse genetics. Comparative transcript analysis of platelets and their precursor cell, the megakaryocyte, together with nucleated blood cell elements, endothelial cells, and erythroblasts, identified novel platelet membrane proteins with hitherto unknown roles in thrombus formation. We determined the phenotype induced by antisense morpholino oligonucleotide (MO)-based knockdown of 5 of these genes in a laser-induced arterial thrombosis model. To validate the model, the genes for platelet glycoprotein (GP) IIb and the coagulation protein factor VIII were targeted. MO-injected fish showed normal thrombus initiation but severely impaired thrombus growth, consistent with the mouse knockout phenotypes, and concomitant knockdown of both resulted in spontaneous bleeding. Knockdown of 4 of the 5 novel platelet proteins altered arterial thrombosis, as demonstrated by modified kinetics of thrombus initiation and/or development. We identified a putative role for BAMBI and LRRC32 in promotion and DCBLD2 and ESAM in inhibition of thrombus formation. We conclude that phenotypic analysis of MO-injected zebrafish is a fast and powerful method for initial screening of novel platelet proteins for function in thrombosis. ispartof: BLOOD vol:113 issue:19 pages:4754-4762 ispartof: location:United States status: published
- Published
- 2009
17. UbcH10 has a rate-limiting role in G1 phase but might not act in the spindle checkpoint or as part of an autonomous oscillator
- Author
-
Jonathon Pines, Lars Koop, Takahiro Matsusaka, Claire Acquaviva, and Adam Walker
- Subjects
Cell cycle checkpoint ,G1 Phase ,Mitosis ,Cell Biology ,Cyclin A ,Spindle Apparatus ,G2-M DNA damage checkpoint ,Biology ,Cell cycle ,Cell biology ,Spindle checkpoint ,Mitotic exit ,Ubiquitin-Conjugating Enzymes ,Humans ,Anaphase-promoting complex ,G1 phase ,HeLa Cells - Abstract
Ubiquitin-dependent proteolysis mediated by the anaphase-promoting complex/cyclosome (APC/C) ubiquitin ligase lies at the heart of the cell cycle. The APC/C targets mitotic cyclins for destruction in mitosis and G1 phase and is then inactivated at S phase, thereby generating the alternating states of high and low cyclin-Cdk activity required for the alternation of mitosis and DNA replication. Two key questions are how the APC/C is held in check by the spindle-assembly checkpoint to delay cells in mitosis in the presence of improperly attached chromosomes, and how the APC/C is inactivated once cells exit mitosis. The ubiquitin-conjugating protein UbcH10 has been proposed to be crucial in the answers to both questions. However, here we show that the behaviour of UbcH10 is inconsistent with both a crucial role in the spindle checkpoint and in inactivating the APC/C as part of an autonomous oscillator. Instead, we find that the rate-limiting role of UbcH10 is only at the end of G1 phase, just before DNA replication begins.
- Published
- 2008
18. Engineered Repressible Lethality for Controlling the Pink Bollworm, a Lepidopteran Pest of Cotton
- Author
-
Tarig Dafa'alla, Thomas A. Miller, Luke Alphey, John Claus, Robert T. Staten, Neil I. Morrison, Thea Marubbi, Ernest Miller, Claire L. Harris, Guoliang Fu, Sinead O'Connell, Matthew J. Epton, Li Jin, Guolei Tang, Adam Walker, Gregory S. Simmons, and Michelle Walters
- Subjects
Heterozygote ,Agricultural Biotechnology ,lcsh:Medicine ,Gossypium ,Fluorescence ,Animals, Genetically Modified ,Sterile insect technique ,Transformation, Genetic ,Integrated Control ,Genetics ,Animals ,Transgenes ,lcsh:Science ,Pest Control, Biological ,Biology ,Larva ,Multidisciplinary ,biology ,business.industry ,Genetically Modified Organisms ,lcsh:R ,Homozygote ,fungi ,Pupa ,Pest control ,Agriculture ,biology.organism_classification ,Survival Analysis ,Sustainable Agriculture ,Biotechnology ,Genetically modified organism ,Lepidoptera ,Blotting, Southern ,Horticulture ,Phenotype ,lcsh:Q ,Pest Control ,PEST analysis ,Genetic Engineering ,business ,Zoology ,Entomology ,Research Article ,Transgenics ,Pink bollworm - Abstract
The sterile insect technique (SIT) is an environmentally friendly method of pest control in which insects are mass-produced, irradiated and released to mate with wild counterparts. SIT has been used to control major pest insects including the pink bollworm (Pectinophora gossypiella Saunders), a global pest of cotton. Transgenic technology has the potential to overcome disadvantages associated with the SIT, such as the damaging effects of radiation on released insects. A method called RIDL (Release of Insects carrying a Dominant Lethal) is designed to circumvent the need to irradiate insects before release. Premature death of insects' progeny can be engineered to provide an equivalent to sterilisation. Moreover, this trait can be suppressed by the provision of a dietary antidote. In the pink bollworm, we generated transformed strains using different DNA constructs, which showed moderate-to-100% engineered mortality. In permissive conditions, this effect was largely suppressed. Survival data on cotton in field cages indicated that field conditions increase the lethal effect. One strain, called OX3402C, showed highly penetrant and highly repressible lethality, and was tested on host plants where its larvae caused minimal damage before death. These results highlight a potentially valuable insecticide-free tool against pink bollworm, and indicate its potential for development in other lepidopteran pests.
- Published
- 2012
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.